2022 NeuroAbilities Virtual Symposium
Unlocking the BCI and Neurotech Market for Persons with Disabilities
As neurotechnologies (NT), including Brain-Computer Interfaces (BCI), evolve rapidly, what are their pathways to marketable solutions for Persons with Disabilities? What is their market potential? How can their design and applications best serve Persons with Disabilities? How can barriers to adoption be lifted and neuroethics challenges resolved?
Join for a three-part series NeuroAbilities Virtual Symposium discussion with experts from different stakeholder groups, including U.S. Food and Drug Administration, industry leaders, end users, advocates, and funders.
Event dates and timing: March 30, March 31, April 1, 2022
Each day from 11:00 A.M. - 12:30 P.M. ET (US & Canada)
- Day 1: The Neurotech Opportunity for Persons with Disabilities
- Day 2: Regulatory Frameworks & Alternative Paths for Direct-to-Consumer Technologies
- Day 3: Neuroethics & Disability Rights
Featured Speakers include:
- Timothy Brown, Ph.D., Assistant Professor, Department of Bioethics & Humanities, University of Washington, School of Medicine
- Jennifer Collinger, Ph.D., Associate Professor, Department of Physical Medicine and Rehabilitation, University of Pittsburgh Heather Dean, Ph.D., Assistant Director, Acute Injury Devices Team, CDRH, U.S. Food & Drug Administration
- Sandy Hanebrink, OTR/L, CLP, FAOTA, Executive Director, Touch the Future Inc.; promoter of the Walk2Walk Campaign
- Amy Kruse, General Manager, Prime Movers Lab
- Michael McKinley, Ph.D., Co-founder and VP, SuitX
- Khara Ramos, Ph.D., Vice President, Dana Foundation, former NIH Neuroethics Director
- Julia Slocomb, Ph.D., Lead Reviewer, CDRH, U.S. Food & Drug Administration
- Roger O. Smith, Ph.D., Professor, Occupational Sciences & Technology, College of Health Sciences, University of Wisconsin-Milwaukee and Director of the Rehabilitation Research Design & Disability (R2D2) Center, and more!
View the Complete Agenda
Register Now to Access All Three Days!
Note: The symposium will be held via Zoom Conferencing. Sign language and live captioning will be provided.
About NeuroAbilities: NeuroAbilities is G3ict’s dedicated program to explore the current state of assistive solutions based on advanced Neurotechnologies, Brain-Computer Interfaces (BCI) and Artificial Intelligence (AI) enabling persons with disabilities and older persons to better interact with their environment. Read more at the NeuroAbilities Program page and visit the NeuroAbilities website for more information.
